Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Snx5 | Rat | (-)-demecolcine | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of SNX5 mRNA | CTD | PMID:23649840 | Snx5 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Snx5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX5 mRNA | CTD | PMID:36331819 | Snx5 | Rat | 1,1-dichloroethene | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of SNX5 mRNA | CTD | PMID:26682919 | Snx5 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Snx5 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX5 mRNA | CTD | PMID:22206623 | Snx5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Snx5 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of SNX5 mRNA | CTD | PMID:22206623 | Snx5 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Snx5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNX5 mRNA | CTD | PMID:17942748 | Snx5 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of SNX5 mRNA | CTD | PMID:17942748 | Snx5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Snx5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNX5 mRNA | CTD | PMID:17942748 | Snx5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNX5 mRNA | CTD | PMID:34747641 | Snx5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Snx5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNX5 mRNA | CTD | PMID:21570461 | Snx5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNX5 mRNA | CTD | PMID:20106945|PMID:21632981 | Snx5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNX5 mRNA | CTD | PMID:19465110 | Snx5 | Rat | 2,4,6-tribromophenol | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in decreased expression of SNX5 mRNA | CTD | PMID:31675489 | Snx5 | Rat | 2-methylcholine | affects expression | ISO | SNX5 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of SNX5 mRNA | CTD | PMID:21179406 | Snx5 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of SNX5 mRNA | CTD | PMID:39298647 | Snx5 | Rat | 4-phenylbutyric acid | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | 4-phenylbutyric acid results in decreased expression of SNX5 mRNA | CTD | PMID:14583596 | Snx5 | Rat | acrolein | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268|PMID:32845096 | Snx5 | Rat | all-trans-retinoic acid | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SNX5 mRNA | CTD | PMID:23724009 | Snx5 | Rat | alpha-pinene | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | Snx5 | Rat | antirheumatic drug | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of SNX5 mRNA | CTD | PMID:24449571 | Snx5 | Rat | aristolochic acid A | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SNX5 mRNA | CTD | PMID:33212167 | Snx5 | Rat | Aroclor 1254 | decreases expression | ISO | Snx5 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of SNX5 mRNA | CTD | PMID:23650126 | Snx5 | Rat | arsane | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Snx5 | Rat | arsenic atom | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Snx5 | Rat | benzo[a]pyrene | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SNX5 mRNA | CTD | PMID:19770486 | Snx5 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | SNX5 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SNX5 mRNA | CTD | PMID:19150397 | Snx5 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SNX5 mRNA | CTD | PMID:25181051 | Snx5 | Rat | bisphenol A | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SNX5 protein | CTD | PMID:31675489 | Snx5 | Rat | bisphenol A | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SNX5 mRNA | CTD | PMID:33221593 | Snx5 | Rat | bisphenol A | affects expression | ISO | SNX5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of SNX5 mRNA | CTD | PMID:30903817 | Snx5 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SNX5 gene | CTD | PMID:28505145 | Snx5 | Rat | cadmium dichloride | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of SNX5 mRNA | CTD | PMID:38174414|PMID:38568856 | Snx5 | Rat | cobalt dichloride | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of SNX5 mRNA | CTD | PMID:19320972 | Snx5 | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SNX5 mRNA | CTD | PMID:24386269 | Snx5 | Rat | crocidolite asbestos | increases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in increased expression of SNX5 mRNA | CTD | PMID:18687144 | Snx5 | Rat | DDE | increases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of SNX5 mRNA | CTD | PMID:38568856 | Snx5 | Rat | decabromodiphenyl ether | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of SNX5 protein | CTD | PMID:31675489 | Snx5 | Rat | dicrotophos | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of SNX5 mRNA | CTD | PMID:28302478 | Snx5 | Rat | enzyme inhibitor | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Snx5 | Rat | epoxiconazole | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SNX5 mRNA | CTD | PMID:35436446 | Snx5 | Rat | ethanol | affects splicing | ISO | Snx5 (Mus musculus) | 6480464 | Ethanol affects the splicing of SNX5 mRNA | CTD | PMID:30319688 | Snx5 | Rat | ethyl methanesulfonate | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of SNX5 mRNA | CTD | PMID:23649840 | Snx5 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of SNX5 mRNA | CTD | PMID:30307764 | Snx5 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of SNX5 mRNA | CTD | PMID:24793618 | Snx5 | Rat | folic acid | multiple interactions | ISO | Snx5 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX5 mRNA | CTD | PMID:22206623 | Snx5 | Rat | formaldehyde | increases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SNX5 mRNA | CTD | PMID:20655997 | Snx5 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SNX5 mRNA | CTD | PMID:22061828|PMID:33387578 | Snx5 | Rat | ivermectin | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SNX5 protein | CTD | PMID:32959892 | Snx5 | Rat | manganese atom | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Snx5 | Rat | manganese(0) | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Snx5 | Rat | manganese(II) chloride | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Snx5 | Rat | methyl methanesulfonate | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of SNX5 mRNA | CTD | PMID:23649840 | Snx5 | Rat | N-acetyl-beta-D-glucosamine | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Acetylglucosamine results in decreased expression of SNX5 mRNA | CTD | PMID:18047607 | Snx5 | Rat | N-acetyl-D-glucosamine | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Acetylglucosamine results in decreased expression of SNX5 mRNA | CTD | PMID:18047607 | Snx5 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SNX5 protein | CTD | PMID:26558463 | Snx5 | Rat | nickel sulfate | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of SNX5 mRNA | CTD | PMID:22714537 | Snx5 | Rat | nitrates | multiple interactions | ISO | Snx5 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNX5 more ... | CTD | PMID:35964746 | Snx5 | Rat | ozone | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268|PMID:32845096|PMID:35430440 | Snx5 | Rat | paracetamol | affects expression | ISO | Snx5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SNX5 mRNA | CTD | PMID:17562736 | Snx5 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SNX5 mRNA | CTD | PMID:33387578 | Snx5 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Snx5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX5 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Snx5 | Rat | piroxicam | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Piroxicam results in decreased expression of SNX5 mRNA | CTD | PMID:21858171 | Snx5 | Rat | propiconazole | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | propiconazole results in increased expression of SNX5 mRNA | CTD | PMID:21278054 | Snx5 | Rat | resveratrol | increases expression | ISO | SNX5 (Homo sapiens) | 6480464 | resveratrol results in increased expression of SNX5 mRNA | CTD | PMID:25888808 | Snx5 | Rat | ritodrine | decreases expression | ISO | Snx5 (Mus musculus) | 6480464 | Ritodrine results in decreased expression of SNX5 mRNA | CTD | PMID:23370008 | Snx5 | Rat | silicon dioxide | decreases expression | ISO | Snx5 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of SNX5 mRNA | CTD | PMID:19073995 | Snx5 | Rat | silicon dioxide | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of SNX5 mRNA | CTD | PMID:25351596 | Snx5 | Rat | sodium arsenite | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SNX5 mRNA; sodium arsenite results in decreased expression more ... | CTD | PMID:22714537|PMID:38228842|PMID:38568856 | Snx5 | Rat | sodium arsenite | multiple interactions | ISO | SNX5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Snx5 | Rat | sodium arsenite | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SNX5 protein | CTD | PMID:29044176 | Snx5 | Rat | sodium arsenite | affects expression | ISO | SNX5 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of SNX5 mRNA | CTD | PMID:29319823 | Snx5 | Rat | tetrachloromethane | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SNX5 mRNA | CTD | PMID:27339419|PMID:31919559 | Snx5 | Rat | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of SNX5 protein | CTD | PMID:35544339 | Snx5 | Rat | titanium dioxide | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SNX5 mRNA | CTD | PMID:23557971 | Snx5 | Rat | trichostatin A | increases expression | ISO | SNX5 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SNX5 mRNA | CTD | PMID:24935251 | Snx5 | Rat | trimellitic anhydride | increases expression | ISO | Snx5 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SNX5 mRNA | CTD | PMID:19042947 | Snx5 | Rat | valproic acid | affects expression | ISO | Snx5 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SNX5 mRNA | CTD | PMID:17292431 | Snx5 | Rat | valproic acid | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SNX5 mRNA | CTD | PMID:23179753|PMID:29154799 | Snx5 | Rat | valproic acid | decreases methylation | ISO | SNX5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of SNX5 gene | CTD | PMID:29154799 | Snx5 | Rat | valproic acid | affects expression | ISO | SNX5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SNX5 mRNA | CTD | PMID:25979313 | Snx5 | Rat | vincristine | decreases expression | ISO | SNX5 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of SNX5 mRNA | CTD | PMID:23649840 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















